Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology/Urology | Endocrinology | Rheumatology | Cardiology/Vascular Diseases
Clinical Trials: Nephritis
A listing of clinical trials currently looking for volunteers to enroll in Nephritis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
California
Los Angeles : Mohamed A. El-Shahawy Updated
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
Colorado
Centennial : IMMUNOe International Research Centers Updated
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
Connecticut
Danbury : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Illinois
Chicago : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Kansas
Kansas City : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
New York
Lake Success : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Manhasset : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
New York : Columbia University Medical Center, Division of Nephrology, Glomerular Center
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Springfield Gardens : Clinical Research Development Associates, LLC Updated
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
North Carolina
Raleigh : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Ohio
Columbus : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Pennsylvania
Duncansville : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Duncansville : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Tennessee
Chattanooga : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Memphis : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Memphis : Ramesh Gupta Updated
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
Texas
Amarillo : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Carrollton : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Dallas : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Belgium
Brussels : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Leuven : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Roeselare : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
China
Beijing :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Fujian :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Hubei :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Hunan :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Jiangsu :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
View More »
Jilin :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Liaoning :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shandong :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shanghai :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shanxi :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Sichuan :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Zhejiang :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
France
Paris Cedex 13 : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Hong Kong
Hong Kong : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Japan
Chubu :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Hokkaido :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kansai :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kantou :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kyusyu :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
View More »
Shagoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Shikoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Touhoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Korea, Republic of
Busan :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Daegu :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Daejeon :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Gwangju :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Incheon :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
View More »
Jeonju :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Seoul :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Malaysia
Kuala Lumpur : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Mexico
Guadalajara, Jalisco : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Mexico : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Mexico : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Mexico : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
México : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Netherlands
Maastricht : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Rotterdam : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Poland
Gdansk : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Wroclaw : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Thailand
Bangkok : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
Chiang Mai : Updated
A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis
